Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Hassan Calls For Greater Transparency in Pharmaceutical Industry
Senator Maggie Hassan of New Hampshire recently wrote an op-ed for Modern Healthcare in which she opined on the need for increased…
Senate Finance Committee Releases Proposed Drug Pricing Legislation
On September 25, 2019, the Senate Finance Committee, led by Chairman Chuck Grassley, released the text of its long-awaited bill…
Grassley Expresses Concern Over DOJ Dismissal of FCA Cases
Earlier this month, Senator Chuck Grassley sent a letter to Attorney General William Barr, expressing concern over the Department…
Pelosi Draft Plan Would Allow Price Negotiations on Select Drugs
A supposed draft plan summary to lower drug prices by House Speaker Nancy Pelosi has been circulating around Capitol Hill…
Concerns About Unintended Consequences of Drug Pricing Transparency Bills
As we previously reported, the House Energy and Commerce Health Subcommittee held a hearing on May 21, 2019 on improving drug…
Senators Grassley and Wyden Expand Their Opioid Investigation to Tax-Exempt…
In 2012 Senators Grassley and Baucus sent letters to the American Pain Society and other pain-related organizations including the…
Senate Health Subcommittee Releases Discussion Draft of Legislation to…
Senate Health Committee Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) released bipartisan discussion…
Biopharma Executives Answer Senate Finance Committee Questions on Policies…
During the Senate Finance Committee hearing earlier this year addressing Drug Pricing in America, the committee posed questions to…
House E&C Panel Republicans Push Back on Drug Transparency Bills
The House Energy and Commerce Health Subcommittee held a hearing on improving drug pricing transparency and lowering prices for…
MedPAC Provides Congress Policy Options to Reigning-In Specialty Drug…
On April 4-5, 2019, the Medicare Payment Advisory Committee (“MedPAC”) held a public meeting in Washington, DC to discuss issues…